2025 United Kingdom Blood Stream Infection Testing Market Revenue Opportunities Report
Description
The 2025 United Kingdom Blood Stream Infection Testing Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Stream Infection Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Bloodstream Infection Testing Market in the United Kingdom are F. Hoffmann-La Roche Ltd. (Roche), Becton Dickinson (BD), bioMérieux SA, and Danaher Corporation. Roche, headquartered in Switzerland, is a prominent player known for systems such as the cobas Liat and LightCycler PCR System, widely used in infection diagnostics. Becton Dickinson, with its global reach, develops advanced technologies for blood culture testing and has established collaborations to reduce contamination and improve test accuracy in hospitals. French company bioMérieux offers expertise in infectious disease diagnostics and has a strong market presence in Europe, including the UK. Danaher Corporation, based in the US but globally active, is involved in expanding product portfolios in this market and implementing growth strategies such as acquisitions and partnerships.
These companies contribute significantly to the UK bloodstream infection testing market, valued at USD 27.7 million in 2023 and projected to reach USD 31.8 million by 2030 with a CAGR of 2%. The UK market benefits from advanced diagnostic technologies and established partnerships between diagnostic firms and healthcare providers. Products like reagents and consumables lead revenue segments, driven by demands for quicker, reliable pathogen identification to manage sepsis and hospital-acquired infections effectively. The participation of these four firms involves ongoing product innovation, regulatory approvals, and collaborations that enhance infection control and patient outcomes across UK healthcare settings.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Stream Infection Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Bloodstream Infection Testing Market in the United Kingdom are F. Hoffmann-La Roche Ltd. (Roche), Becton Dickinson (BD), bioMérieux SA, and Danaher Corporation. Roche, headquartered in Switzerland, is a prominent player known for systems such as the cobas Liat and LightCycler PCR System, widely used in infection diagnostics. Becton Dickinson, with its global reach, develops advanced technologies for blood culture testing and has established collaborations to reduce contamination and improve test accuracy in hospitals. French company bioMérieux offers expertise in infectious disease diagnostics and has a strong market presence in Europe, including the UK. Danaher Corporation, based in the US but globally active, is involved in expanding product portfolios in this market and implementing growth strategies such as acquisitions and partnerships.
These companies contribute significantly to the UK bloodstream infection testing market, valued at USD 27.7 million in 2023 and projected to reach USD 31.8 million by 2030 with a CAGR of 2%. The UK market benefits from advanced diagnostic technologies and established partnerships between diagnostic firms and healthcare providers. Products like reagents and consumables lead revenue segments, driven by demands for quicker, reliable pathogen identification to manage sepsis and hospital-acquired infections effectively. The participation of these four firms involves ongoing product innovation, regulatory approvals, and collaborations that enhance infection control and patient outcomes across UK healthcare settings.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
